EFM
CATX icon

E Fund Management’s Perspective Therapeutics CATX Stock Holding History

E Fund Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.7K Buy
+11,667
New +$49.3K ﹤0.01% 489

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

E Fund Management's CATX Position: Q1 2026 in Review

E Fund Management opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 11,667 shares worth $48.7K. The stake represents ﹤0.01% of the portfolio and ranks #489 among its holdings.

138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • E Fund Management held 11,667 shares of Perspective Therapeutics worth $48.7K as of Q1 2026.
  • Perspective Therapeutics was a new E Fund Management position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #489 holding.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.